Published in Med Pediatr Oncol on January 01, 1985
Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. J Clin Oncol (2008) 0.94
Hepatoblastoma: an oncological review. Pediatr Radiol (2006) 0.92
Cisplatin therapy in infants: short and long-term morbidity. Br J Cancer Suppl (1992) 0.83
Rare Tumors in Children: Progress Through Collaboration. J Clin Oncol (2015) 0.83
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma. Int J Mol Sci (2015) 0.78
Unresectable hepatoblastoma: current perspectives. Hepat Med (2017) 0.75
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med (1986) 3.27
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1991) 3.16
An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell (1990) 3.02
Crystalline Serotonin. Science (1948) 2.96
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol (1994) 2.94
Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci U S A (1992) 2.42
Chromosome translocation in peripheral neuroepithelioma. N Engl J Med (1984) 2.22
Cytogenetic features of human neuroblastomas and cell lines. Cancer Res (1981) 2.21
Myeloid neoplasia in children treated for solid tumours. Lancet (1990) 2.18
Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med (1984) 2.09
Method for the earlier recognition of abnormal stature. Arch Dis Child (1983) 2.02
There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys (1999) 1.96
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol (1996) 1.90
Evidence for the existence of two types of cAMP binding sites in aggregating cells of Dictyostelium discoideum. Cell (1975) 1.89
Alveolar soft part sarcoma in children and adolescents: clinical features and outcome of 11 patients. Med Pediatr Oncol (1996) 1.85
Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol (1989) 1.85
Cytobrush in collection of cervical specimens for detection of Chlamydia trachomatis. J Clin Microbiol (1989) 1.84
Amplification of the gli gene in childhood sarcomas. Cancer Res (1989) 1.84
Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol (1995) 1.73
Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol (2000) 1.70
Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells? Am J Surg Pathol (2001) 1.68
Clinical manifestations of ganglioneuroma. Cancer (1989) 1.66
Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatr Blood Cancer (2004) 1.61
Isolation of transplantable erythroleukemia cells from mice infected with helper-independent Friend murine leukemia virus. Blood (1981) 1.61
A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet (1987) 1.60
Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors. J Clin Oncol (1995) 1.58
Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene (1990) 1.53
Recurrent childhood lymphocytic leukemia following cessation of therapy: treatment and response. Cancer (1976) 1.53
Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol (1998) 1.52
Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1994) 1.51
Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity. Cancer (1995) 1.49
Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children. J Clin Oncol (1999) 1.41
Ability of circular extrachromosomal DNA molecules to carry amplified MYCN proto-oncogenes in human neuroblastomas in vivo. J Natl Cancer Inst (1990) 1.38
Wilms' tumor: reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology. Int J Radiat Oncol Biol Phys (1990) 1.38
Is renal salvage feasible in unilateral Wilms' tumor? Proposed computed tomographic criteria and their relation to surgicopathologic findings. Am J Pediatr Hematol Oncol (1990) 1.38
Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience. Cancer (2000) 1.37
Colon carcinoma in children and adolescents. A review of 30 cases. Cancer (1985) 1.36
Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res (1987) 1.31
Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors. J Clin Oncol (1994) 1.29
Rhabdomyosarcoma complicating multiple neurofibromatosis. J Pediatr (1978) 1.26
Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy. Cancer Res (1972) 1.25
Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene (1994) 1.25
Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Leuk Lymphoma (2004) 1.24
Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features. Cancer (1999) 1.22
Immunologic rebound after cessation of long-term chemotherapy in acute leukemia. Blood (1972) 1.22
High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol (1993) 1.19
Response of childhood rhabdomyosarcoma to combination chemotherapy. J Pediatr (1969) 1.18
A new familial cancer syndrome? A spectrum of malignant and benign tumors including retinoblastoma, carcinoma of the bladder and other genitourinary tumors, thyroid adenoma, and a probable case of multifocal osteosarcoma. J Natl Cancer Inst (1977) 1.18
Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol (1996) 1.18
Breast metastases in children with rhabdomyosarcoma. Cancer (1980) 1.17
Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma. Cancer Res (1987) 1.17
Comparison of constitutional and tumor-associated 11;22 translocations: nonidentical breakpoints on chromosomes 11 and 22. Proc Natl Acad Sci U S A (1986) 1.16
Sarcomas (other than Ewing's) of flat bones in children and adolescents. A clinicopathologic study. Cancer (1990) 1.15
Metastatic epidural tumors in children. Med Pediatr Oncol (1982) 1.15
Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. J Clin Oncol (2001) 1.15
Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res (1998) 1.14
Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol (1993) 1.13
Teratoid Wilms' tumor: the St Jude experience. J Pediatr Surg (1988) 1.13
Therapy of localized and regional lymphosarcoma of childhood. Cancer (1971) 1.11
The Xenopus oocyte as a surrogate secretory system. The specificity of protein export. Eur J Biochem (1980) 1.11
Duration and severity of fatty metamorphosis of the liver following L-asparaginase therapy. Cancer (1971) 1.09
Hearing loss in children receiving cisplatin chemotherapy. J Pediatr (1983) 1.09
Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer (2001) 1.08
Dechloroethylation of ifosfamide and neurotoxicity. Lancet (1986) 1.06
Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer (1992) 1.06
Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital. J Clin Oncol (1999) 1.06
Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide. Cancer (1993) 1.04
Orbital development in long-term survivors of retinoblastoma. J Clin Oncol (1997) 1.04
Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol (1994) 1.04
An exploratory study of environmental and medical factors potentially related to childhood cancer. Med Pediatr Oncol (1991) 1.04
Brain metastases in children with melanoma. Cancer (1997) 1.03
Brain metastases in osteosarcoma. Report of a long-term survivor and review of the St. Jude Children's Research Hospital experience. Cancer (1993) 1.03
Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J Natl Cancer Inst (1984) 1.03
Statistical analysis of cytogenetic abnormalities in human cancer cells. Cancer Genet Cytogenet (1982) 1.02
Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. Ophthalmology (2001) 1.02
Synovial sarcoma in children and adolescents: the St Jude Children's Research Hospital experience. J Clin Oncol (1994) 1.02
The natural history of colorectal carcinoma in adolescents. Cancer (1982) 1.02
How are men with urethral discharge managed in general practice? Int J STD AIDS (1998) 1.01
Cytogenetic studies in non-African Burkitt lymphoma. Blood (1980) 1.01
Sequestration of PHA-responsive cells (T-lymphocytes) in the bone marrow of leukemic children undergoing long-term immunosuppressive therapy. J Immunol (1972) 1.01
Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group. J Clin Oncol (2000) 1.00
Combined therapy for malignant tumors of the chest wall in children. J Pediatr Surg (1977) 1.00
Colorectal carcinoma in adolescents implications regarding etiology. Cancer (1977) 0.99
Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A Pediatric Oncology Group Phase II study. Cancer (1993) 0.99
Oncogene amplification in pediatric brain tumors. Cancer Res (1990) 0.99
Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study. J Clin Oncol (1993) 0.99
Adjuvant chemotherapy for osteosarcoma of the extremity. Long-term results of two consecutive prospective protocol studies. Cancer (1990) 0.99
Survival of children with neuroblastoma treated with combination chemotherapy. J Pediatr (1968) 0.98
Childhood multifocal osteosarcoma. Clinicopathologic and radiologic correlates. Cancer (1985) 0.98
Paratesticular rhabdomyosarcoma: delayed effects of multimodality therapy and implications for current management. Cancer (1994) 0.98
Phonon-assisted electroluminescence from metallic carbon nanotubes and graphene. Nano Lett (2010) 0.97
Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity. J Clin Oncol (1994) 0.97
Fatal "iron heart" in an adolescent: biochemical and ultrastructural aspects of the heart. Pediatrics (1975) 0.96
Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity. Cancer (1981) 0.96